Axelar AB
πΈπͺSweden
- Country
- πΈπͺSweden
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.axelar.se
A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors
Phase 1
Completed
- Conditions
- Solid TumorsHematological Malignancies
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 13
- Registration Number
- NCT01725555
- Locations
- πΈπͺ
KFUE, Uppsala, Sweden
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Phase 2
Completed
- Conditions
- Non-small-cell Lung CancerSquamous Cell CarcinomaAdenocarcinoma of the Lung
- Interventions
- Drug: AXL1717Drug: Docetaxel
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 100
- Registration Number
- NCT01561456
- Locations
- π§πΎ
Gomel Regional Clinical Oncology Center, Gomel, Belarus
ππΊUniversity of Debrecen Medical and Health Science Center, Clinic of Pulmonology, Debrecen, Hungary
π΅π±Wladyslaw Bieganski Regional Specialist Hospital, Grudziadz, Poland
A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)
Phase 1
Completed
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: AXL1717
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2012-11-12
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 12
- Registration Number
- NCT01466647
- Locations
- πΈπͺ
KFUE, Uppsala, Sweden
πΈπͺUniversity Hospital, Uppsala, Sweden
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- Drug: AXL1717
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2011-09-15
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 49
- Registration Number
- NCT01062620
- Locations
- πΈπͺ
Uppsala University Hospital, Uppsala, Sweden
Β© Copyright 2025. All Rights Reserved by MedPath